Research, Society and Development, v. 15, n. 9, e7315951679, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i9.51679 NeuroSense: A preliminary usability evaluation of a system to prevent the worsening of diabetic foot conditions NeuroSense: Uma avaliação preliminar da usabilidade de um sistema para prevenir o agravamento das condições do pé diabético NeuroSense: Una evaluación preliminar de la usabilidad de un sistema para prevenir el empeoramiento de las afecciones del pie diabético Received: 09/05/2026 | Accepted: 09/19/2026 | Published: 09/20/2026 Felipe Rodrigues Moreira dos Santos ORCID: https://orcid.org/0009-0001-2024-0939 Federal University of Uberlândia, Brazil E-mail: axfeliperodrigues@gmail.com Mariana de Oliveira ORCID: https://orcid.org/0009-0002-3084-7475 Federal University of Uberlândia, Brazil E-mail: oliveiramariana39@gmail.com Laura Caroline Felipe de Freitas ORCID: https://orcid.org/0000-0002-5670-3675 Federal University of Uberlândia, Brazil E-mail: lauracffreitas03@gmail.com Samuel de Oliveira Lino ORCID: https://orcid.org/0000-0001-6760-8326 Federal University of Uberlândia, Brazil E-mail: laura.felipe@ufu.br Isadora Ramos Tozette ORCID: https://orcid.org/0009-0001-6807-5055 Federal University of Uberlândia, Brazil E-mail: isadora.tozette@ufu.br Sérgio Ricardo de Jesus Oliveira ORCID: https://orcid.org/0000-0003-2294-2018 Federal University of Uberlândia, Brazil E-mail: srjesus@ufu.br Abstract Diabetes mellitus is one of the fastest-growing global health emergencies and represents a substantial burden on healthcare systems worldwide. Among its metabolic complications, diabetic neuropathy is highly prevalent and may cause loss of nerve function, increasing the risk of plantar overload and diabetic foot ulcers. To address this challenge, NeuroSense was developed as a wearable system designed to monitor plantar pressure and provide real-time vibrotactile feedback when excessive pressure is detected in predefined areas of the foot. The present study aimed to evaluate the usability and safety of the device, ensuring that its use does not cause adverse effects. This pilot feasibility study included four healthy participants who used the system during two consecutive periods of 2.5 hours while performing their usual activities. Following the intervention, two questionnaires were administered to assess participants’ perceived ability to modify their gait pattern in response to vibrotactile feedback and their overall experience with the system. The System Usability Scale was used as a quantitative measure of volunteers’ impressions. The questionnaire 1, which assessed the level of gait pattern redefinition, yielded an average score of 80.63, demonstrating a fair level of effectiveness of the prototype in inducing changes in user behavior. Questionnaire 2, which evaluated the usability of the system, yielded a mean SUS score of 83.13, corresponding to an excellent usability rating. Overall, the findings support the feasibility and favorable usability of the NeuroSense system in healthy participants, although further studies with larger and clinical populations are warranted. Keywords: Diabetes Mellitus; Diabetic Neuropathies; Self-Help Devices. Resumo O Diabetes Mellitus é uma das emergências globais de saúde que mais crescem e representa uma carga substancial para os sistemas de saúde em todo o mundo. Entre suas complicações metabólicas, a neuropatia diabética é altamente prevalente e pode causar perda da função nervosa, aumentando o risco de sobrecarga plantar e úlceras do pé diabético. 1 Research, Society and Development, v. 15, n. 9, e7315951679, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i9.51679 Para enfrentar esse desafio, o NeuroSense foi desenvolvido como um sistema vestível projetado para monitorar a pressão plantar e fornecer feedback vibrotátil em tempo real quando uma pressão excessiva é detectada em áreas predefinidas do pé. O presente estudo teve como objetivo avaliar a usabilidade e a segurança do dispositivo, garantindo que seu uso não cause efeitos adversos. Este estudo piloto de viabilidade incluiu quatro participantes saudáveis, que utilizaram o sistema durante dois períodos consecutivos de 2,5 horas, enquanto realizavam suas atividades habituais. Após a intervenção, dois questionários foram aplicados para avaliar a capacidade percebida dos participantes de modificar seu padrão de marcha em resposta ao feedback vibrotátil e sua experiência geral com o sistema. A System Usability Scale foi utilizada como uma medida quantitativa da impressão dos voluntários. O questionário 1, que avaliou o nível de redefinição do padrão de marcha, apresentou uma pontuação média de 80,63, demonstrando um nível razoável de eficácia do protótipo em induzir mudanças no comportamento dos usuários. O questionário 2, que avaliou a usabilidade do sistema, apresentou uma pontuação média SUS de 83,13, correspondente a uma classificação de usabilidade excelente. De modo geral, os resultados apoiam a viabilidade e a usabilidade favorável do sistema NeuroSense em participantes saudáveis, embora sejam necessários estudos adicionais com populações maiores e clínicas. Palavras-chave: Diabetes Mellitus; Neuropatias Diabéticas; Tecnologia Assistiva. Resumen La Diabetes Mellitus es una de las emergencias mundiales de salud que más rápidamente están creciendo y representa una carga sustancial para los sistemas de salud en todo el mundo. Entre sus complicaciones metabólicas, la neuropatía diabética es altamente prevalente y puede causar pérdida de la función nerviosa, aumentando el riesgo de sobrecarga plantar y úlceras del pie diabético. Para hacer frente a este desafío, NeuroSense fue desarrollado como un sistema portátil diseñado para monitorear la presión plantar y proporcionar retroalimentación vibrotáctil en tiempo real cuando se detecta una presión excesiva en áreas predefinidas del pie. El presente estudio tuvo como objetivo evaluar la usabilidad y la seguridad del dispositivo, garantizando que su uso no cause efectos adversos. Este estudio piloto de viabilidad incluyó a cuatro participantes sanos, quienes utilizaron el sistema durante dos períodos consecutivos de 2,5 horas, mientras realizaban sus actividades habituales. Después de la intervención, se aplicaron dos cuestionarios para evaluar la capacidad percibida de los participantes para modificar su patrón de marcha en respuesta a la retroalimentación vibrotáctil y su experiencia general con el sistema. La System Usability Scale fue utilizada como una medida cuantitativa das impresiones de los voluntarios. El cuestionario 1, que evaluó el nivel de redefinición del patrón de marcha, presentó una puntuación media de 80,63, demostrando un nivel razonable de eficacia del prototipo para inducir cambios en el comportamiento de los usuarios. El cuestionario 2, que evaluó la usabilidad del sistema, presentó una puntuación media SUS de 83,13, correspondiente a una clasificación de usabilidad excelente. En general, los resultados respaldan la viabilidad y la usabilidad favorable del sistema NeuroSense en participantes sanos, aunque son necesarios estudios adicionales con poblaciones más grandes y clínicas. Palabras clave: Diabetes Mellitus; Neuropatías Diabéticas; Dispositivos de Autoayuda. 1. Introduction In 2021, the International Diabetes Federation (IDF) concluded that Diabetes Mellitus is among the fastest-growing global health emergencies of the century, accounting for approximately 11.5% of total healthcare investments worldwide (Magliano et al., 2021). Among the metabolic complications caused by hyperglycemia, diabetic neuropathy (DN) has a high prevalence among patients (Albers & Pop-Busui, 2014; Fowler, 2008; Hicks & Selvin, 2019). Characterized by peripheral nerve dysfunction, distal symmetric polyneuropathy (DSP) is the most frequent form of DN, leading to gradual loss of nerve function, especially in distal limbs, and, in more severe cases, resulting in ulcers and amputations (Boulton et al., 2005; Hicks et al., 2016; Strand et al., 2024). Ulcers are skin erosions identified by the loss of epithelial tissue that progresses to deeper layers of the skin, exposing them to infectious agents. In the case of DN, DFUs (Diabetic Foot Ulcers) are caused by neurological, vascular, and subcutaneous factors linked to disturbances in the metabolism of carbohydrates, fats, and proteins in the diabetic body (Reiber et al., 1998; Deng et al., 2023). DFUs are strongly associated with the physical difficulties faced by patients due to the loss of sensation in distal limbs; they are unable to regulate their posture and maintain balance, resulting in impaired mobility and high risks of falling (Rinkel et al., 2019; Timar et al., 2016). Mental difficulties are also reported, including higher rates of socialization challenges, anxiety, depression, pain, suicidal behavior, and economic difficulties due to treatment expenses and routine adaptations resulting from DFUs (Al-Smadi et al., 2025). Furthermore, this group presents higher mortality rates, 2 Research, Society and Development, v. 15, n. 9, e7315951679, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i9.51679 approximately 44% within a five-year period (Sekhar et al., 2015; Moulik et al., 2003; Hoban et al., 2015; Raghav et al., 2018; Chammas et al., 2016; Chin et al., 2024). Another aggravating factor is DFU recurrence, which affects 6.2% to 41.4% of patients after healing (Sun et al., 2024). Determinants associated with poor healing include advanced target organ disease and the inability to walk independently (Prompers et al., 2008). The tendency for wounds to worsen and lead to amputation can be avoided with appropriate treatment according to their severity. Typically, debridement, dressings and local care, offloading, vascular assessment, treatment of active infections, and glycemic control are the set of actions taken to treat DFUs. Additionally, alternatives such as oxygen-based therapies, stem cell therapy, electrical therapies and negative pressure therapies are being explored, focusing on wound healing (Everett & Mathioudakis, 2018; Lim et al., 2017). Despite the variety of existing treatments, there is still a discrepancy between the outcomes desired by patients and healthcare professionals and reality. Less complex treatment measures capable of reducing the risk of infection and the need for hospitalization are still in high demand by patients dealing with the high recurrence of DFUs and who constantly require clinical interventions. In this sense, wearable technologies stand out for their potential to automate part of the treatment and, consequently, increase adherence to self-care (Miller et al., 2014; Armstrong et al., 2017; Castro-Martins et al., 2024; Kosaji et al., 2025). To address this challenge, NeuroSense has been developed. It is a wearable system designed to monitor plantar pressure and provide real-time vibrotactile feedback when excessive pressure is detected in predefined areas of the foot. The system consists of three main components: a sensing unit, a control unit, and an alert unit. The sensing unit comprises a tactile insole with nine pressure sensors distributed across key plantar regions and an electronic module that wirelessly transmits pressure data to a smartphone. The control unit, implemented through a smartphone application, allows the configuration of pressure thresholds and stimulation parameters, receives and processes sensor data, and stores the collected information for subsequent visualization and analysis. When pressure in a predefined plantar region exceeds the established threshold, the system identifies a pressure peak and sends a command to the alert unit, a wearable vibrostimulator positioned on the user's waist. The device then delivers a programmed vibratory stimulus to the skin, providing sensory feedback intended to prompt the user to modify their gait and redistribute plantar pressure. In this way, NeuroSense is designed to support the protection of vulnerable plantar areas by promoting gait adaptation in response to excessive mechanical loading, with potential applications in the prevention of plantar injuries and in the management of existing lesions. This study aimed to evaluate the usability and safety of the device, ensuring that its use does not cause adverse effects. Therefore, it represents a preliminary evaluation of the system. Following this initial phase, the device will be tested in patients presenting symptoms compatible with diabetic neuropathy and its complications, in order to determine whether NeuroSense can effectively fulfill its intended purposes 2. Methodology This study is characterized as a pilot feasibility study with an interventional and prospective design. It was conducted to evaluate the proper functioning of the NeuroSense system, identify potential technical limitations or failures among its different components, and assess the safety and tolerability of its use in healthy volunteers. The evaluation included the assessment of potential foot injuries or discomfort associated with the tactile insole, the comfort and stability of the vibrostimulator when attached to the user’s skin, the adequate perception and tolerability of the vibratory stimulus, and the absence of any other adverse effects. In addition, the study aimed to determine whether participants could appropriately 3 Research, Society and Development, v. 15, n. 9, e7315951679, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i9.51679 interpret the vibratory stimulus and modify their gait pattern in response to excessive plantar pressure, as well as to identify potential limitations in the use of the smartphone application, including its comprehensibility, ease of use, and intuitiveness. Participants were followed prospectively throughout the experimental protocol and underwent two consecutive periods of 2.5 hours each, corresponding to the different stages of system use. The experimental group was selected using a convenience sampling approach, with participants recruited through the dissemination of an invitation document describing the study and its selection process. Four participants were included according to the following eligibility criteria: being 25 years of age or older, having no diagnosis of diabetic neuropathy, and presenting no symptoms compatible with diabetic foot syndrome. The absence of diabetic neuropathy was assessed using the Brazilian version of the Michigan Neuropathy Screening Instrument (MNSI-Brazil), a validated screening tool for the identification of diabetic peripheral neuropathy. The experimental protocol was designed to evaluate the user experience with the NeuroSense system across two main aspects: the participant’s ability to adjust their gait pattern in response to vibratory feedback to protect a specific plantar region from excessive pressure, and the overall usability of the system. A mixed-methods study, combining qualitative and quantitative approaches (Gil, 2026; Risemberg et al., 2026a), was conducted, using a Likert scale to convert qualitative data into quantitative data (Risemberg et al., 2026b) and concepts of simple descriptive statistics with: data classes, absolute frequency values (counts), and mean scores values, in text (Shitsuka et al., 2014; Vieira, 2021). The System Usability Scale (SUS) was used as a quantitative tool to assess the participants’ experience. The SUS was selected because it is a simple, practical, and objective instrument that can be easily administered to participants and is appropriate for evaluating the usability of technological systems. The instrument consists of ten statements rated on a fivepoint Likert scale, ranging from 1 (“strongly disagree”) to 5 (“strongly agree”), providing an overall measure of the user’s perceived experience with the system. To minimize response bias, odd-numbered items are positively worded, whereas evennumbered items are negatively worded. As this study involved human participants, the research protocol was submitted to and approved by the Research Ethics Committee for Human Research - CAAE: 78770924.1.0000.5152. 3. Results and Discussion The device was tested on participants under the supervision of the research team. To ensure comfort during its usage, the insole was placed inside a closed shoe belonging to the user, and the vibrotactile stimulation module was attached to the user’s waist. Volunteers were instructed to perform walking activities and to remain standing at rest, allowing the recording of the mean plantar pressure levels across different regions of the foot in the absence of vibratory stimulation. Subsequently, they were instructed to perform the same activities while intentionally controlling the pressure applied to a specific plantar site, which was randomly selected to simulate the presence of a plantar lesion. This was achieved by adopting different gait patterns aimed at reducing the mechanical load on the selected region. The pressure values recorded during this stage were used to characterize the expected pressure distribution patterns across different regions of the insole and to calibrate the system. These measurements also served to establish the pressure thresholds required to trigger the vibratory stimulus in response to excessive loading at the selected plantar site. Following the calibration procedure, each participant was instructed to use NeuroSense for two consecutive periods of 2.5 hours each, while performing usual daily activities, including walking, sitting, and standing up. At the end of each period, the participant completed questionnaires addressing specific aspects of the device experience. The first questionnaire assessed 4 Research, Society and Development, v. 15, n. 9, e7315951679, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i9.51679 the perception of the vibratory stimulus and the participant’s ability to appropriately adjust their gait pattern in response to the feedback, whereas the second evaluated the overall usability of the system. The usability of the NeuroSense system was quantitatively assessed using the System Usability Scale (SUS). The instrument consists of 10 statements rated on a five-point Likert scale, ranging from 1 (“strongly disagree”) to 5 (“strongly agree”). The SUS scoring procedure accounts for the alternating positive and negative wording of the items. For the oddnumbered items (1, 3, 5, 7, and 9), one point is subtracted from the original response score, whereas for the even-numbered items (2, 4, 6, 8, and 10), the response score is subtracted from 5. Thus, each item contributes a value ranging from 0 to 4, with higher values consistently representing more favorable evaluations of the system. The adjusted scores for the ten items are then summed, resulting in a value ranging from 0 to 40, and multiplied by 2.5 to obtain the final SUS score, which ranges from 0 to 100. The resulting score represents a global measure of perceived usability, with higher scores indicating better perceived experience. For interpretation, the numerical SUS score was classified according to the acceptability ranges, letter grades, and adjective ratings proposed by Bangor et al. (2009). These classifications were developed from a large database of SUS evaluations and were intended to facilitate the interpretation of the otherwise abstract 0 to 100 score. In this framework, scores above approximately 85 are associated with an “Excellent” adjective rating and an A+ grade, scores around 80 and 85 with “Excellent”/A, 74 and 80 with “Good”/B, and 68 and 74 with “Good”/C; lower scores correspond to marginal or unacceptable usability. The following table presents the questions used in Questionnaires 1 and 2, including the items administered to assess participants’ perceptions of gait adjustment in response to vibrotactile feedback and the overall usability of the NeuroSense system. Table 1 - Questionaries 1 and 2. Item (Question) Questionnaire 1: Evaluation of the level of gait pattern adjustment Questionnaire 2: Evaluation of NeuroSense’s system usability. Perceptions Perceptions 01 I found it really simple to adjust my gait pattern based on the vibratory stimulus. I found it easy to install the NeuroSense system on my shoe and attach the vibro-stimulator to my clothing. 02 Even when perceiving the vibratory stimulation, I found it very difficult to adjust my gait pattern. I felt I needed to pay close attention when installing NeuroSense on the shoe and attaching the vibro-stimulator to the clothing. 03 I found some vibratory stimulation patterns easier to perceive, which made me adjust my gait pattern quickly. I found NeuroSense easy to use. 04 Regardless of the active vibratory stimulation pattern, it was difficult to perceive it, and therefore, I took time to learn a new gait pattern. I felt I would need help from a technical person to be able to use the NeuroSense system. 05 I found the intensity of the vibratory stimulation easy to perceive. I felt that the various functions of NeuroSense were well integrated. 06 I felt the stimulation intensity should be slightly stronger to be better perceived. I think NeuroSense presents a lot of inconsistencies. 07 I noticed that whenever I received a vibratory stimulus, I automatically changed my gait pattern. I imagine that most people could learn to use NeuroSense quickly. 08 Even perceiving the vibratory stimulus, I took time to adjust my gait pattern, which resulted in additional vibratory stimuli. I found the NeuroSense system very complex to use. 09 After a short period of use, I was able to adjust my gait pattern and stopped receiving vibratory stimuli. 5 I felt very confident using NeuroSense. Research, Society and Development, v. 15, n. 9, e7315951679, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i9.51679 Even managing to adjust my gait pattern to stop the vibratory stimulus, I often reverted to incorrect gait, causing additional stimuli. 10 I needed to learn many things before I could use NeuroSense. Source: Created by Authors. Table 1 - SUS scores based on questionnaire 1 (Q1) and questionnaire 2 (Q2) Volunteer 1 2 3 4 Mean Sum of SUS Scores Q1 (0–40) 33 31 34 31 32.25 Final Score Q 1 (0–100) 82.5 77.5 85 77.5 80.63 Sum of SUS Scores Q2 (0–40) 33 29 33 38 33,25 Final Score Q 2 (0–100) 82,5 72,5 82,5 95 83,13 Source: Created by Authors. In addition to the usability assessment, two complementary questions addressing participants’ perceived comfort and willingness to use the NeuroSense system regularly in their daily lives were analyzed. As presented in the following table, Question 1, with a positive connotation, yielded a mean score of 4.0 on a 5-point scale, indicating an overall positive perception of the device. In contrast, Question 2, which addressed discomfort and potential reluctance toward frequent use, yielded a mean score of 2.0, suggesting that discomfort was not a predominant concern among participants. Taken together, the responses indicate that participants generally perceived the NeuroSense system as comfortable and expressed willingness to incorporate it into their daily routines, if necessary. Nevertheless, the findings also suggest opportunities for further refinement of the system’s ergonomic design and user experience, which may contribute to greater comfort, acceptance, and adherence during regular use. Table 2 - Responses to questions regarding the potential for continued use of the NeuroSense system. Question 1 I felt comfortable and could use it frequently Question 2 NeuroSense made me uncomfortable and I wouldn’t use it frequently 1 2 3 4 4 3 4 5 1 2 3 2 Average 4 2 Volunteer Source: Created by Authors. The questionnaire 1, which assessed the level of gait pattern redefinition based on vibratory stimulation, yielded an average score of 80.63. According to the classification by Bangor et al. (2009), this score indicates an acceptable usability, demonstrating a fair level of effectiveness of the prototype in inducing changes in user behavior. The second questionnaire, which evaluated the usability, obtained an average score of 83.13, placing the prototype in the excellent usability range, according to the same reference. When analyzing the usability of the NeuroSense system through the interpretation of Questionnaire 2, it can be observed that, among the positively worded items, the question related to the ease of installing the wearable system presented the highest mean score, 4.75/5, indicating that the proper positioning of the device components was perceived as particularly simple by the participants. The questions related to the level of integration of 6 Research, Society and Development, v. 15, n. 9, e7315951679, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i9.51679 the different components and the level of confidence during system use also stood out, both with a mean score of 4.50/5. These results demonstrate that the communication protocol used in NeuroSense functioned adequately during the tests and was capable of interconnecting, within the appropriate time frame, information regarding the distribution of plantar pressure in the volunteers and the need for gait modification when a peak was identified, without perceptible delays in data transmission and processing. Furthermore, the confidence reported by the participants during device use indicates that its operation was perceived as intuitive and that the learning curve required for autonomous use of the equipment is probably not extensive. A finding that supports this interpretation is the mean response score for Question 7, which was 4.00/5 and assessed the participants’ perception that most people could quickly learn to use the system. This result suggests that NeuroSense presents an accessible operational interface, which is an important characteristic for a device intended to be used repeatedly in daily routines. In addition, the negatively worded items generally presented low mean scores, which also represents a favorable result. Question 6, which assessed the presence of inconsistencies in the system, presented the lowest mean score, 1.25/5. This result indicates that the functionalities proposed for the device were perceived by users during the tests and were consistent with the participants’ expectations regarding how the proposed system should operate to achieve the primary objective of the study. Similarly, Questions 2 and 8 presented mean scores of 1.50/5, suggesting that participants did not consider it necessary to pay excessive attention during installation nor did they perceive the system as excessively complex. Despite these predominantly positive results, Question 4 was the negatively worded item with the highest mean score (2.75/5), corresponding to the statement “I felt I would need help from a technical person to be able to use the NeuroSense system.” This result deserves attention because it indicates a perceived need for technical support when initially using the device. In comparison, Question 10, which assessed the need to learn many things before using the system, presented a mean score of 1.75/5, reinforcing that the main difficulty does not appear to be related to the amount of knowledge required to operate the device, but potentially to specific aspects of its use that may require initial guidance or technical assistance. 4. Conclusion Overall, the findings indicate that NeuroSense has significant potential to modify gait patterns while also offering a favorable usability profile, with participants reporting positive perceptions regarding its installation, integration of components, ease of learning, and confidence during use. These findings are further supported by the low perception of inconsistencies and complexity, indicating the system could potentially be incorporated into routine use without requiring extensive learning. Despite the overall positive assessment, the results also identified a potential limitation related to the need for initial technical assistance. This need for additional support may imply an indispensable role for a healthcare professional in introducing and explaining the system’s basic functionalities, which may not be fully understood if the device were obtained independently by the user. In the context of commercialization or implementation within healthcare services, this requirement could increase the costs and operational complexity associated with deploying the system. However, these findings do not demonstrate that NeuroSense has an effect on the prevention or reduction of diabetic foot ulcers. This potential remains to be clinically validated in a subsequent study involving a larger and more robust sample, specifically including individuals with diabetic neuropathy, who represent the target population most likely to benefit from the proposed intervention. Such a study will be necessary to determine whether the observed usability and functional characteristics of the system translate into meaningful clinical outcomes. 7 Research, Society and Development, v. 15, n. 9, e7315951679, 2026 (CC BY 4.0) | ISSN 2525-3409 | DOI: http://dx.doi.org/10.33448/rsd-v15i9.51679